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Prions are proteins that convert between structurally
and functionally distinct states, one or more of which
is transmissible. In yeast, this ability allows them to
act as non-Mendelian elements of phenotypic inher-
itance. To further our understanding of prion biology,
we conducted a bioinformatic proteome-wide survey
for prionogenic proteins in S. cerevisiae, followed by
experimental investigations of 100 prion candidates.
We found an unexpected amino acid bias in aggrega-
tion-prone candidates and discovered that 19 of
these could also form prions. At least one of these
prion proteins, Mot3, produces a bona fide prion in
its natural context that increases population-level
phenotypic heterogeneity. The self-perpetuating
states of these proteins present a vast source of heri-
table phenotypic variation that increases the adapt-
ability of yeast populations to diverse environments.
INTRODUCTION
The prion hypothesis posits that biological information can be
replicated solely through self-propagating conformations of
proteins. Though it was initially conceived to explain baffling
neurodegenerativediseases inmammals (Griffith, 1967;Prusiner,
1982), it has since grown to encompass a number of non-Mende-
lian traits in fungi (Ross et al., 2005b; Shorter and Lindquist, 2005;
Shkundina and Ter-Avanesyan, 2007). All known prions, except
for the initially discovered disease-causing prion PrP, are benign,
and in some cases can confer selectable advantages (Saupe
et al., 2000; True and Lindquist, 2000; True et al., 2004). The
self-templating property of prions makes them both conforma-
tionally and epigenetically dominant, and positions prion-forming
proteins as metastable cellular switches of protein function.
The realization that protein conformational switches could
provide a means for inheritance of phenotypes dates back
15 years (Wickner, 1994), yet only a few proteins with this146 Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc.capacity have been discovered (Shorter and Lindquist, 2005;
Du et al., 2008). Most of these have been found in the yeast
S. cerevisiae,with the [PSI+] element being the best understood.
[PSI+] is caused by an amyloid-like aggregated state of the
translation-termination factor Sup35p. In the prion state, the
majority of Sup35p molecules are inactive, resulting in increased
levels of nonsense suppression (Liebman and Sherman, 1979;
Patino et al., 1996) and programmed frameshifting (Namy
et al., 2008). This gives rise to RNA stability changes and func-
tionally altered polypeptides and consequently to phenotypes
that can be advantageous under diverse conditions (Eaglestone
et al., 1999; True et al., 2004). Remarkably, the ability of Sup35p
to switch into a prion conformation, and the regulation of that
switch by the protein remodeling factor Hsp104p, have been
conserved for over 800million years of fungal evolution (Chernoff
et al., 2000; Zenthon et al., 2006).
Three other amyloid-based prions, formed by the functionally
diverse proteins Ure2p, Rnq1p, and Swi1p, have been described
in S. cerevisiae. Ure2p regulates nitrogen catabolism; its prion
state, [URE3], attenuates this activity resulting in the constitutive
utilization of poor nitrogen sources (Aigle and Lacroute, 1975;
Wickner, 1994). The Rnq1p protein in its prion state, [RNQ+]
(also called [PIN+]), enhances the inducibility of other prions
(Derkatch et al., 2000; Bradley et al., 2002). [SWI+], the most
recently discovered prion, is caused by an inactive state of the
chromatin remodeling factor Swi1p (Du et al., 2008). Intriguingly,
[SWI+] represents the first established link between chromatin-
based and prion-based epigenetics, although a biological rele-
vance of this connection remains to be elucidated. Indeed, for
all of these prion proteins, the putative functionality of their prion
forms is highly debated (Nakayashiki et al., 2005).
The conformational duality of amyloid-based prions resides in
structurally independent prion-forming domains (PrDs) (Edskes
et al., 1999; Li and Lindquist, 2000; Santoso et al., 2000; Sond-
heimer and Lindquist, 2000). These PrDs are modular and can
be transferred to other proteins to create novel prions (Li and
Lindquist, 2000). They have a very unusual amino acid composi-
tion: enriched for polar residues such as glutamine (Q) and aspar-
agine (N) and depleted of hydrophobic and charged residues.
This composition promotes a disordered molten-globule-like
conformational ensemble, within which amyloid-nucleating
contacts can be made (Serio et al., 2000; Wang et al., 2006;
Mukhopadhyay et al., 2007).
The ability of prions to propagate is afforded by the inherent
and extremely efficient self-templating capacity of amyloid,
a highly ordered b sheet-rich protein aggregate. The amyloid-
like prion state nucleates in cells at a low frequency de novo,
but once formed, efficiently propagates this change to soluble
conformers (Patino et al., 1996; Glover et al., 1997). Prion
domains also form self-propagating amyloid in vitro under phys-
iological conditions (Glover et al., 1997; Taylor et al., 1999), and
remarkably, the resulting fibers alone can transform cells to the
corresponding prion state (Sparrer et al., 2000; Maddelein
et al., 2002; Brachmann et al., 2005; Patel and Liebman, 2007),
firmly establishing the protein-only nature of prion inheritance.
However, the relationship between amyloid polymerization
and prion propagation is still poorly understood. In fact, most
known amyloid-forming proteins are not prions, and even
amyloids of prion proteins are not always transmissible (Diaz-
Avalos et al., 2005; Salnikova et al., 2005; Baskakov and Breydo,
2007; Sabate et al., 2007).While specific sequence elements ulti-
mately determine the intrinsic amyloidogenic properties of poly-
peptides (Liu and Lindquist, 1999; Lopez de la Paz and Serrano,
2004; Alexandrov et al., 2008), there are multiple trans-acting
factors within the cell, including molecular chaperones, the cyto-
skeletal machinery, and nucleating factors such as [PIN+], that
interactwith amyloidprions at every stageof propagation (Chern-
off, 2007; Perrett and Jones, 2008). These observations, and our
lack of knowledge of the pervasiveness of amyloid-based biolog-
ical phenomena, create a need to elucidate the amyloid-prion
relationship on a comprehensive, genome-wide level.
Such a genome-wide analysis could also reveal new prion-
basedphenotypes,whichwouldsupport the idea thatprion-medi-
ated phenotypic variation is functionally significant. Prion-like
Q/N-rich proteins are abundant in the proteomes of lower eukary-
otes, with 100 to 170 such sequences inS. cerevisiae (Michelitsch
andWeissman, 2000; Harrison andGerstein, 2003). However, the
experimental tools needed to determine the prion properties of
these proteins in a systematic manner have been lacking. Conse-
quently, other than the four aforementioned prions, only one addi-
tional yeast protein, New1p, has been shown to harbor a domain
capable of forming a prion, albeit in an artificial context (Oshero-
vich and Weissman, 2001).
We bioinformatically scanned the yeast genome for proteins
with prion-like character. We then subjected the highest-scoring
candidates to genetic, cell biological, and biochemical assays to
discern their prion-forming capacity, ultimately determining that
at least 24 yeast proteins contain a prion-forming domain. We
further evaluated one of these, Mot3p, confirming that it is
a bona fide prion with a phenotype that is likely to be advanta-
geous under certain environmental conditions.
RESULTS
A Bioinformatics Screen Reveals Multiple Prion
Candidates in Yeast
We developed a hidden Markov Model (HMM)-based approach
for predicting prions, using the experimentally determined priondomains (PrDs) of Sup35p, Ure2p and Rnq1p, and the prion
candidate New1p as positive training examples (at the time,
Swi1p had not yet been shown to be a prion). We did not in-
corporate the other known fungal prion protein, HET-s, nor the
mammalian prion protein, PrP, into our model because these
proteins have unique sequences that are dissimilar in amino
acid composition from the other prion proteins and thus would
decrease the predictive power of the model. We acknowledge
that our approach is thus necessarily biased toward a particular
class of prions, but is nevertheless merited by the large number
of Q/N-rich yeast proteins with unknown prion potential. All
yeast protein sequences were parsed into prion-like regions
and nonprion (background) regions. Proteins with prion-like
regions at least 60 amino acids long (denoted ‘‘cores’’) were
considered to be prion candidates, based on the lower size limit
of previously characterized yeast prion domains (Masison and
Wickner, 1995; King and Diaz-Avalos, 2004). These proteins
were then ranked by their core scores. Figure 1A shows an
example of the output format of our prediction for the PrD of
Sup35p.
Our query revealed 200 proteins that have candidate PrDs
(cPrDs) in the S. cerevisiae genome (see Table S1 for the
complete set of predictions). The list of candidate prions includes
Sup35p and Rnq1p as well as the prion candidate New1p in the
group of the top 20 candidates. Although the recently discovered
Swi1p prion (Du et al., 2008) was not used for training of the algo-
rithm, it ranks at position 21, indicating that our prediction is
a valuable tool to uncover new prions. To evaluate these candi-
dates, we tested the amyloid and prion-forming properties of
the 100 highest-scoring cPrDs (Figure 1).
Many cPrDs Form Foci in the Cytosol
As a first step to experimentally characterize the cPrDs, we
investigated their propensity to form foci in living yeast cells by
transiently expressing them as chimeras with yellow fluorescent
protein (cPrD-EYFP). Several studies have described two
morphologically distinct forms of protein aggregation in the yeast
cytosol (Derkatch et al., 2001; Ganusova et al., 2006; Taneja
et al., 2007). One of these structures has a ring- or ribbon-like
appearance and is localized around the vacuole and/or adjacent
to the plasma membrane, whereas the other is more punctate
and preferentially resides close to the vacuole. We performed
pilot experiments with known prions and amyloidogenic proteins
to gain a better understanding of the aggregation structures that
can be visualized by fluorescence microscopy. We transiently
expressed these proteins as EYFP fusions using a galactose-
regulatable promoter (Figure 2A). The PrDs of Sup35p and
Ure2p proceeded through a characteristic maturation pathway
that included an early stage with ribbon-like aggregation
patterns and a later stage with puncta (Tyedmers and Lindquist,
manuscript in preparation; Derkatch et al., 2001; Ganusova et al.,
2006). In contrast, the PrD of Rnq1p and an expanded Q-rich
region of the huntingtin protein almost exclusively formed
puncta, when expressed from the same promoter.
Despite the intrinsically unfolded nature of the cPrDs, the
expression levels of most of the fusions were robust, with a
few outliers that expressed at only low levels (see Figure S1
available with this article online). A large fraction (69%) of theCell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc. 147
Figure 1. Computational Prediction and Outline of the Prion Screen
(A) Output format of the cPrD prediction algorithm for Sup35p. The core region of the cPrD is highlighted in orange and additional predicted regions in pink. The top
panel shows the probability of each residuebelonging to theHMMstate ‘‘cPrD’’ (red) and ‘‘background’’ (black); the tracks ‘‘MAP’’ and ‘‘Vit’’ illustrate theMaximum
a Posteriori and the Viterbi parses of the protein into these two states. The lower panel shows sliding averages over a window of width 60 of net charge (pink),
hydropathy (blue), and predicted disorder (gray) as in FoldIndex (Prilusky et al., 2005), along with a sliding average based on cPrD amino acid propensities (red).
(B) Overview of the experimental procedures employed to screen for new Q/N-rich prions in yeast. Based on our computational prediction, we generated a cPrD
library that was shuttled into a panel of expression vectors for analysis. Experiments were performed with cPrDs expressed in bacteria and yeast and included
biochemical assays, cell biological assays and different aggregate visualization techniques.cPrD-EYFP fusions formed fluorescent foci (Figures 2B and S2).
The proteins produced a surprising diversity of patterns with
a large variety of ribbon-like structures and punctate foci. Over-
all, punctate patterns were much more abundant than ribbon
structures and ranged from one large focus to multiple small
foci distributed all over the cytoplasm. Since foci formation is
also a feature of many nonprion proteins, we conducted addi-
tional experiments to assess the biochemical properties of the
cPrDs.148 Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc.Multiple cPrDs Form Highly Stable Aggregates
Protein aggregates can differ substantially in terms of detergent
stability and can adopt either highly ordered (amyloid fibril) or
disordered (amorphous) superstructures. To determine whether
the cPrDs formed aggregates, and if so, whether they formed
prion-like structures, we used semi-denaturing detergent-
agarose gel electrophoresis (SDD-AGE). SDD-AGE allows for
the resolution of a wide size-range of SDS-resistant (amyloid-
like) aggregates, ranging from oligomeric species to polymers
Figure 2. Prion Domains Form Intracellular Aggregates Detectable by Microscopy and SDD-AGE
(A) Expression of amyloidogenic proteins in the yeast cytosol leads to the formation of ribbon and dot-like structures. cPrD-EYFP fusion proteins were expressed
from a galactose-regulatable plasmid in yeast cells containing the [RNQ+] prion. The yeast cells were subjected to fluorescencemicroscopy after 24 hr of expres-
sion. Representative fluorescence microscopy images are shown together with DIC images (insets). Arrows point to aggregates in the yeast cytosol.
(B) A selected set of cPrD candidates forming fluorescent foci after 24 hr of expression. Conditions were as described in (A).
(C) Detection of SDS-resistant aggregates by SDD-AGE in cell lysates of yeast strains expressing cPrD-EYFP fusions. Expression of the proteins was induced for
24 hr (top gels) or 48 hr (bottom gels). Control proteins (highlighted in blue) were the N or NMdomains of Sup35p (top left) and the huntingtin protein length variants
Q25, Q72 and Q103 (bottom right). Proteins were detected with a GFP-specific antibody. Previously identified prions and the prion candidate New1p are high-
lighted in red.assembled from hundreds of individual polypeptides (Bagriant-
sev et al., 2006; Halfmann and Lindquist, 2008).
Lysates from cells expressing cPrD-EYFP chimeras were
analyzed by SDD-AGE after 24 hr of expression (Figure 2C).
Remarkably, about one third of the cPrD-EYFP fusions had the
SDS-resistance properties of known amyloidogenic proteins
(the N and NM domains of Sup35p and the 72Q and 103Q frag-
ments of huntingtin), including all four experimentally verified
prions and the prion candidate New1p.
Since amyloid formation is time- and concentration-dependent,
we increased the timeof transient expression to 48 hr. Despite onlymodest increases in the cellular levels of the cPrDs (2- to 3-fold),
additional proteins became SDS-resistant, now including almost
half the set of investigated cPrDs, with an enrichment for those
that scored highly in our algorithm. The ratio of aggregated to
solubleproteindiffered ina time-dependentmanner foreachcandi-
date and was strongly reproducible. Some cPrD-EYFP fusions
were completely aggregated after 24 hr, whereas others initially
exhibiteda small fractionof aggregatedprotein that increasedafter
48hrofexpression (seeTableS2 foraclassification). Inaddition,we
observed substantial variation in the range of particle sizes, and
again these were reproducible for individual cPrDs.Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc. 149
Multiple cPrDs Form Amyloid In Vitro
Purified PrDs of known prions form amyloid in vitro. To assess
amyloid propensities of our candidate prion domains in the
absence of cellular factors, we purified bacterially expressed
cPrDs under denaturing conditions, and then analyzed amyloid
formation following dilution into a physiological buffer containing
thioflavin-T (ThT). ThT is a dye that does not interfere with
amyloid assembly, but changes its fluorescence properties
upon amyloid binding (LeVine, 1993, 1997).
Overall, the cPrDs displayed tremendous diversity in amyloid
propensities (Figure 3). Many, including the four known prions,
largely completed amyloid formation within 12 hr. Others did
not acquire ThT fluorescence until well over 24 hr after dilution
from denaturant (e.g., Pan1p and Yap1801p). Most positive
samples initially had very little fluorescence, consistent with
nucleated polymerization that is a hallmark of amyloid assembly.
Finally, roughly half of the proteins were unable to nucleatewithin
the time-frame examined.
PrDs can follow both amyloid and nonamyloid aggregation
pathways (Liu et al., 2002; Vitrenko et al., 2007; Douglas et al.,
2008), and some nonamyloid b-sheet structures can alter ThT
fluorescence (LeVine, 1993). As an additional characterization,
we therefore assayed the SDS resistance of samples after 72 hr
using a filter retardation assay (Scherzinger et al., 1999). In this
assay, a nonbinding membrane is used to detect protein aggre-
gates, which, due to their size, are specifically retained on the
membrane surface. Treating the impeded aggregates with SDS
then distinguishes amyloid from nonamyloid, since nonamyloid
aggregates become solubilized and flow through.
We found remarkable agreement between the ThT and filter
retardation amyloid assays (Figure 3). Acquisition of moderate
to strong ThT fluorescence (>100 AFU) coincided with SDS-
stable aggregation in every case. Several cPrDs (e.g., those of
Snf5p and Nab3p) formed aggregates that were retained by the
filter in nondenaturing conditions (0.1% Tween 20) but were
eliminated by SDS. Interestingly, this type of aggregate was
only observed when ThT fluorescence was absent or greatly
delayed, andonlywith proteins thatweremoreenriched for gluta-
mines than asparagines. In total, the amyloid propensities of
isolated cPrDs were in good agreement with the aggregation of
thesecPrDs in vivo (seeFigureS3andTableS2 for acomparison).
A Sup35p-Based Prion Assay Identifies Phenotypic
Switching Behavior
To determine whether the cPrDs can confer a heritable switch
in the function of the protein to which they are attached, we
employedanassaybasedon thewell-characterizedprionpheno-
types of the translation termination factor Sup35p. Sup35p
consists of anN-terminal PrD (N), a highly chargedmiddledomain
(M) and C-terminal domain (C), which provides the translation
termination function. The PrDs of Sup35p and other prions are
modular and can be transferred to nonprion proteins, thereby
creating new protein-based elements of inheritance (Li and Lind-
quist, 2000). This property allowed us to generate cPrD-SUP35C
chimeras (under the control of the constitutive ADH1 promoter)
that could be tested for their ability to generate [PSI+]-like states,
as previously reported for Rnq1p and New1p (Sondheimer and
Lindquist, 2000; Osherovich and Weissman, 2001).150 Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc.Because Sup35p is an essential protein, we first generated
a strain in which a deletion of the chromosomal SUP35 was
coveredbyaSup35p-expressingplasmid (FigureS4).When these
cells were transformed with cPrD-SUP35C expression plasmids,
a URA3 marker on the covering SUP35 plasmid allowed it to be
selected against in 5-FOA-containing medium (plasmid shuffle).
The resulting strains contained cPrD-Sup35C fusions as their
only source of functional Sup35p. Each was tested for the ability
to forma heritable [PSI+] state, using anADE1 allelewith a prema-
ture stop codon. Read-through of this allele in [PSI+] cells creates
two easily monitored phenotypes, the ability to grow on adenine-
deficientmedium, and on completemedium, awhite colony color,
due to the restoration of the adenine biosynthesis pathway, which
prevents accumulation of the red byproduct in [psi-] cells.
We obtained 90 viable cPrD-SUP35C strains upon loss of the
coveringSUP35plasmid (see FiguresS5, S6, andS7 andSupple-
mental Discussion). Interestingly, several strains spontaneously
switched to a white colony color at a high frequency (e.g.,
New1p, Lsm4p, andNrp1p in FigureS5). Switching rates of prions
can be as low as 106 to 107 (Lund and Cox, 1981; Liu and Lind-
quist, 1999;TuiteandCox,2003). Therefore, in caseswherespon-
taneous switching was not observed, we took advantage of
a characteristic of all known prions to induce switching: elevated
expression of the PrD increases the likelihood of conformational
conversion to the prion state. Therefore, we introduced an addi-
tional plasmid with a cPrD-EYFP fusion under the control of
a galactose-inducible promoter. We identified 22 cPrD-SUP35C
strains that showed increased growth on adenine-deficient
medium after transient expression of cPrD-EYFP (Figures 4 and
S8; see Table S2 for a list of positive cPrDs).
A hallmark of prion proteins is that once the conformational
conversion has occurred it is self-sustaining. Thus, transient
overexpression of the protein is sufficient to induce a heritable
change in phenotype. We tested the ability of the Ade+ colonies
to maintain that state on nonselective medium after loss of the
overexpression plasmid. Indeed, on complete medium all of
the 22 cPrD-SUP35C strains displayed a colony color change
from red to white or pink that was maintained over several
rounds of re-streaking (Figure S9).
Sequence Features that Drive Prionogenesis—
Asparagines versus Glutamines
To gain a better understanding of PrD-mediated prion formation,
we compared the sequences of the cPrDs that scored positive in
each of our assays with those that scored negative (Table S5
and Figure S11). Aggregation prone cPrDswere strongly enriched
for asparagines, whereas glutamines, charged residues and
prolinesweremoreabundant innonaggregatingcPrDs.Thisdiffer-
ence was observed in all four assays: foci-formation, SDD-AGE,
in vitro amyloid formation, and cPrD-SUP35C switching. The
strikingdifference in thedistributionofQsandNswasunexpected,
as these have largely been considered to be functionally equiva-
lent drivers of prionogenesis (Michelitsch and Weissman, 2000).
Our analysis on these prionogenic sequences also shows that
the spacing of ‘‘amyloid breaking’’ prolines and charges (Lopez
de la Paz and Serrano, 2004) is an important contribution to
prion formation (Figure S11). Other studies have argued that
prionogenesis is independent of the polypeptide sequence,
Figure 3. Prion Domains Have Diverse Amyloid Propensities
Amyloid formation of cPrD-M-His proteins was followed by ThT fluorescence (arbitrary units) measured at the indicated time points. Shown are means of
three replicate assemblies (coefficients of variation were generally < 30; exceptions were Pan1, Nup116, and Yap1802, which each had highly variable lag
phases). After the final measurement, reactions were analyzed for detergent-resistant aggregation. Aliquots from one experiment were spotted directly onto nitro-
cellulose (‘‘Total’’), or treated with either 0.1% Tween 20 or 2% SDS and filtered through a nonbinding membrane. Retained protein was visualized with Ponceau
S. *These cPrDs were purified with a polyHis-tag only (no M). **These cPrDs were purified with the M-His tag at their N-terminus. Red labels indicate known prion
proteins.provided that amino acid composition is unchanged (Ross et al.,
2004; Ross et al., 2005a). Our findings call for a reinterpretation
of this conclusion. Together, the composition and sequence
biases we have delineated will strongly improve future predic-
tions of amyloid and prion proteins.
Phenotype Switches Involve an Hsp104p-Dependent
Conformational Change
We used SDD-AGE analysis to examine cell lysates of prion-posi-
tiveandprion-negativestrains for changes in theaggregationstate
of the cPrD-Sup35C fusions (Figure 5A and S10A). In accordancewith standard nomenclature, these are hereafter designated
[PrD-C+] and [prd-c-], with brackets designating the non-Mende-
lian character of prion inheritance and capital letters signifying
geneticdominanceof the trait.All 22 fusionsshowedahighamount
of SDS-resistant aggregation in the [PrD-C+] strains, whereas
aggregation was lower or not detectable in the [prd-c-] strains.
All known fungal prions are dependent on chaperones to
induce and maintain a prion state. Prions vary in their depen-
dence on different classes of chaperones, but all amyloid-based
fungal prions are critically dependent on the protein remodeling
factor Hsp104p. Therefore, yeast cells can be cured of prionsCell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc. 151
Figure 4. A SUP35-Based Prion Assay Is Used to Detect Switching Behavior
(A) A schematic overview of the genetic manipulations deployed to identify cPrDs with prion properties (top) and an example of the used selection procedure
(bottom). The prion state was induced by expressing NM-EYFP for 24 hr and the cells were subsequently plated on complete (YPD) and adenine-deficient
medium (SD-ade). The same strain grown under noninducing conditions served as a control. Note that the number of cells plated on SD-ade plates was 200 times
the number on YPD plates. White arrows point to colonies that switched to a white colony color.
(B) A selected set of positive candidates identified with the SUP35C-based prion assay. Conditions were as described in (A).by genetic manipulations that ablate HSP104 gene function or
chemical inhibition of Hsp104p activity (Shkundina and Ter-Ava-
nesyan, 2007). Indeed, passaging of the [PrD-C+] strains on
plates containing 5mMof theHsp104p inhibitor guanidine hydro-
chloride (GdnHCl) eliminated the prion in all but one case, New1p
(Figure 5B and S10B and Supplemental Discussion).
The prion state of the Rnq1p protein enhances the induction of
other yeast prions, most likely by providing an imperfect template
onwhichotheraggregation-proneproteinscannucleate (Salnikova
et al., 2005).We investigated the role of Rnq1p in prion induction by
applying our Sup35p-based system in strains cured of [RNQ+] and
in strains carrying a deletion of the gene encoding Rnq1p. In all 10
cases examined (data not shown) we observed a strong reduction
in the number of Ade+ colonies, indicating that the de novo forma-
tion of [PrD-C+] strains requires the presence of the [RNQ+] prion.
The Prion State Is Transferable to the Endogenous
Protein
To investigate whether the [PrD-C+] states can propagate to the
corresponding endogenous protein, we inserted a C-terminal152 Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc.tag at the chromosomal genetic locus. We limited our analysis
to the subset of 9 candidates that tolerated C-terminal tagging
and whose PrDs were N-terminal or internal. The cell lysates of
the resulting [prd-c-] and [PrD-C+] strains were analyzed by
SDD-AGE and probed for both the endogenously tagged and
chimeric versions of each protein. We detected simultaneous
aggregation of cPrD-Sup35C chimeras and the corresponding
endogenous proteins in all cases (Figure 5C). The fact that we
observed co-aggregation strongly supports the modularity
concept of PrDs and the sequence-specific templating of prions.
These observations suggest that the endogenous proteins can
switch to a prion state, with phenotypic consequences that
could impact the survival and adaptation of yeast cells.
[MOT3+], a Newly Discovered Prion Conferred by Mot3p
Preliminary studies of the refined list of 29 cPrDs (candidates
highlighted in red in Table S2) indicated that several of the full-
length candidate prion proteins are capable of self-sustained
prion aggregation (data not shown). To rigorously establish that
one of these candidates operates as a prion in a physiologically
relevant manner, we focused on one, Mot3p, for which robust
prion-selective assays could be readily predicted. Mot3p is
a globally acting transcription factor that modulates a variety of
processes, including mating, carbon metabolism, and stress
response (Grishin et al., 1998).
Mot3p tightly represses anaerobic genes, such as DAN1,
during aerobic growth. To facilitate analysis of Mot3p transcrip-
tional activity, we created a Mot3p-controlled auxotrophy by
replacing the DAN1 ORF with URA3. The resulting strains nor-
mally could not grow without supplemental uracil. URA3 expres-
sion, and uracil-free growth, should be restored upon reduction
of Mot3p activity, as with MOT3 deletion (Figure 6A) or, poten-
tially, sequestration of Mot3p by prion formation. We transiently
overexpressed Mot3PrD-EYFP for 24 hr, via a galactose-induc-
Figure 5. The Phenotypic Switches of cPrD-
Sup35C Chimeras Involve Amyloid and Are
Curable
(A) Cells lysates were prepared from [prd-c-] and
[PrD-C+] strains and analyzed by SDD-AGE. The
cPrD-Sup35C fusion proteins were detected by
using a C domain-specific anti-Sup35p antibody.
Corresponding [prd-c-] and [PrD-C+] strains
growing on YPD are displayed above the SDD-
AGE western blots.
(B) [PrD-C+] strains were passaged three times on
YPD plates containing 5 mM GdnHCl and then
spotted onto YPD plates (‘‘cured’’). The [prd-c-]
and [PrD-C+] strains are shown for comparison.
(C) cPrD-SUP35C strains with a coding sequence
for Cerulean integrated at the 30 end of the corre-
sponding chromosomal gene were subjected to
an SDD-AGE analysis in the respective [prd-c-]
and [PrD-C+] states. cPrD-Sup35C particles
were detected with a C domain-specific anti-
Sup35p antibody and the particles containing
Cerulean-tagged endogenous protein were
detected with an anti-GFP antibody.
ible promoter, and plated the cells onto
glucose media lacking uracil. We found
that even this transient elevation of intra-
cellular Mot3PrD levels increased the
number of Ura+ dan1::URA3 cells by two
to three orders of magnitude (Figure 6D).
We observed similar results in both
S288C and W303 strain backgrounds
(data not shown). The phenotype per-
sisted even after the inducing plasmid
had been lost (after multiple passages
on nonselective media; Figure 6B). As
expected for a prion-based phenotype,
uracil auxotrophy was dominant in mat-
ings to ura- cells (data not shown). We
then analyzed diploid ura- and Ura+
dan1::URA3 strains by SDD-AGE, taking
advantage of a naturally occurring 6xHis
motif in Mot3p that allowed for its immu-
nodetection. The Ura+ state, but not the
ura- state, corresponded to the presence
of SDS-resistant aggregates of Mot3p (Figure 6C). We hereafter
refer to this heritable state of Mot3p as ‘‘[MOT3+]’’, using stan-
dard prion nomenclature, to reflect its causal determinant.
The strongest evidence that a phenotype is prion-based is the
ability to induce it in prion-free cells by transformation with
recombinant prion amyloid generated in vitro (Sparrer et al.,
2000; Maddelein et al., 2002; Brachmann et al., 2005; Patel
and Liebman, 2007). We produced Mot3PrD amyloid fibers
from bacterially-expressed recombinant protein in vitro. These
fibers strongly stimulated amyloid assembly of soluble Mot3PrD
protein in vitro (Figure 7A). In both the W303 and S288C strain
backgrounds, transformation with Mot3PrD fibers increased
the frequency of Ura+ colonies by 50 fold relative to control
transformations with soluble Mot3PrD (Figure 7B and data notCell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc. 153
shown). These experiments prove not only that [MOT3+] is
a protein-only heritable phenotype, but also that intracellular
Mot3p readily engages in self-perpetuating prion aggregation.
Does this newly identified prion share other characteristics
with well-known yeast prions? Well-characterized yeast prions
rely, at least partially, on the presence of other prions like
[RNQ+] for their efficient appearance. We compared [MOT3+]
induction by transient Mot3PrD-EYFP expression in [RNQ+]
and GdnHCl-treated, [rnq-] strains. Surprisingly, the appearance
of Ura+ colonies was only slightly affected by the prion status
of Rnq1p (Figure 6F). The relative [RNQ+]-independence of
[MOT3+] is unique among characterized yeast prions and
suggests that [MOT3+] may appear frequently in diverse yeast
strains. The ability of Mot3p to bypass a common regulatory
barrier to prion nucleation also indicates that [MOT3+] induction
may have elevated sensitivity to environmental stresses.
Amyloid-based yeast prions also rely on Hsp104p, the only
known cellular factor capable of shearing amyloid fibers, in order
to propagate efficiently. We tested if inactivation of Hsp104p
Figure 6. The Transcription Factor Mot3p
Is a Prion
(A) A Mot3p-reporter strain is Ura+ when Mot3p
is inactive. A dan1::URA3/DAN1 mot3::KanMX4/
MOT3 diploid was sporulated and tetrads
dissected. Shown are five-fold serial dilutions of
four spores from a tetratype tetrad, plated onto
SD-CSM and SD-ura. Spore genotypes are as
indicated.
(B) 5-fold serial dilutions of [mot3-] and [MOT3+]
dan1::URA3 cells were spotted onto YPD and
SD-ura.
(C) Lysates of diploid [mot3-] and [MOT3+] cells
were investigated by SDD-AGE and Western blot-
ting. Mot3p was detected via its naturally occur-
ring 6xHis motif using an anti-His antibody.
(D) Wild-type HSP104 yeast cells and HSP104-
deleted yeast cells, each carrying plasmids for
galactose-inducible expression of either Mot3PrD-
EYFP or control protein EYFP, were compared for
[MOT3+] induction. Two transformants each were
grown over night in galactose media, washed
once inwater, then plated at five fold serial dilutions
to SD-CSM or SD-ura plates.
(E) A [MOT3+] isolate was passaged three times
on YPD plates or YPD plates containing GdnHCl,
and then grown over night in liquid YPD prior to
spotting onto SD-ura plates.
(F) A [RNQ+] dan1::URA3 strain was converted to
[rnq-] by four passages on GdnHCl-containing
plates. The [RNQ+] and [rnq-] strains were
transformed with a Mot3PrD-EYFP plasmid and
assessed for [MOT3+] induction as in (D).
eliminated [MOT3+], using GdnHCl treat-
ment.We found that passaging otherwise
stable [MOT3+] strains on medium con-
taining 5 mM GdnHCl restored them to
the original [mot3-] state (Figure 6E). We
further confirmed that the Hsp104p-
dependence of [MOT3+] was not unique
to this particular isolate, by assaying the de novo inducibility of
[MOT3+] in the absence of HSP104. In these cells, the appear-
ance of Ura+ colonies was severely diminished (Figure 6D).
This effect was observed both for overexpression-induced and
spontaneously appearing Ura+ colonies (the latter arise among
mock-induced cells after extended incubation times). These
results indicate not only that [MOT3+], like all other known yeast
prions, critically requires Hsp104p-mediated fiber shearing for
inheritance, but also that [MOT3+] naturally appears at a detect-
able frequency.
Mot3p regulates a complex cell-wall remodeling program
during adaptation to anaerobiosis, through predominantly gene-
repressive activities (Grishin et al., 1998; Abramova et al., 2001;
Hongay et al., 2002). We reasoned that a prion state of Mot3p
would likely perturb this activity, giving rise to cell wall-related
[MOT3+] phenotypes. Accordingly, we treated [mot3-] and
[MOT3+] cells with the commonly used cell wall stressors, calco-
fluor white and congo red. Hypersensitivity to these agents is
indicative of cell wall defects (Ram et al., 1994; Mrsa et al.,154 Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc.
Figure 7. Mot3p and Swi1p Form Amyloid-
Based Prions that Can Be Beneficial
(A) Mot3PrD amyloid fibers used for fiber transfor-
mation experiments were added at 1% or 10%
(w/w) to fresh 20 mM Mot3PrD amyloid assembly
experiments and monitored for acquisition of ThT
fluorescence. Shown are means +/ STDV.
(B) Mot3PrD-M-His protein was polymerized and
examined for a fibrillar amyloid morphology by
transmission electron microscopy (bar = 100 nm).
[mot3-] spheroplasts were transformed with either
soluble (freshly diluted) or amyloidMot3PrD-M-His
protein and plated directly onto SD-ura plates
containing 1 M sorbitol.
(C) [MOT3+] and [mot3-] isolates were grown over
night in YPD, then spotted (serial 5 fold dilutions)
to SD-ura, YPD, or YPD containing calcofluor
white (50 mg/ml) or congo red (500 mg/ml).
(D) Lysates of diploid [swi-] and [SWI+] cells
carrying an integration of the coding sequence
for EGFP at one of the two chromosomal loci of
the SWI1 gene were investigated by SDD-AGE
andWestern blotting. Swi1p-EGFP fusion proteins
were detected using an anti-GFP antibody.
(E) 5-fold serial dilutions of [swi-] and [SWI+] cells
were spotted onYPDandYPDcontaining benomyl
(5 mg/l).1999). We found that [MOT3+] isolates were relatively resistant to
these agents (Figure 7C), consistent with a modified cell wall
resulting fromderepressionofMot3p-repressedcellwall proteins.
Do other candidates behave as prions? During the course of
our studies, Du and coworkers presented strong genetic
evidence for Swi1p as a prion protein (Du et al., 2008). Swi1p
was one of eleven Q/N-rich proteins reported to allow for
[PSI+]-induction when overexpressed (Derkatch et al., 2001).
We used the [PSI+] co-induction methodology (Du et al., 2008)
to confirm these findings for Swi1p. Previous studies speculated
that the prion-like properties of Swi1p are based on amyloid
aggregation, but direct biochemical evidence had been lacking
(Derkatch et al., 2001; Du et al., 2008). We tested the physical
status of the endogenous full-length Swi1 protein on SDD-AGE
gels. It formed SDS-resistant aggregates in [SWI+] cells but
not in [swi-] cells (Figure 7D). Finally, we asked if the [SWI+] state
might have beneficial consequences under some circumstances
by subjecting cells to a condition previously shown to interact
synthetically with mutations in SWI1 – exposure to the microtu-
bule-inhibiting fungicide benomyl (Hillenmeyer et al., 2008).
Indeed, [SWI+] cells exhibited strong resistance (Figure 7E).
DISCUSSION
We conducted the first comprehensive study of prion-like Q/N-
rich domains in yeast, using three different criteria to investigate
their ability (1) to form amyloid in vivo under physiological condi-
tions; (2) to self-assemble in vitro in the absence of other factors;
and (3) to replicate indefinitely in cells as self-perpetuating epige-
netic elements. We identified 24 protein domains that satisfied
the stringent third criterion for prion behavior. This group includesthe known prions Ure2p, Sup35p, Rnq1p, and Swi1p, the previ-
ously identified prion candidate New1p, and a functionally
diverse set of 19 new candidates.
All but one prion candidate (New1p, see Supplemental Discus-
sion) were strictly dependent on the protein remodeling factor
Hsp104p. Interestingly, most proteins that satisfied the stringent
third criterion also passed criteria one and two (Figure S3), under-
scoring the importance of amyloid’s distinctive self-templating
properties for prion phenomena. In addition, the in vitro aggrega-
tion results compare extremely well with the aggregation of these
cPrDs in vivo, a remarkable finding given the absence in vitro of
the prion regulators [RNQ+] and Hsp104p. Q/N-rich sequences,
despite having overtly similar amino acid compositions, have
biochemical differences that give rise to a range of amyloid
propensities. These differences affect amyloidogenesis intrinsi-
cally, rather than simply by controlling interactions with intracel-
lular prion-promoting factors. Thus, prion-forming proteins are
predisposed to form amyloid even in the absence of factors
that govern prionogenesis in vivo. The implication is, then, that
factors like [RNQ+] and Hsp104p may have evolved, in part, to
regulate the frequency of spontaneous prion appearance and
to promote the stable propagation of prions once they appear.
The dependence of prions on these factors as well as their inter-
action with other chaperones and stress proteins links them intri-
cately with cellular stress pathways (Chernoff, 2007; Shorter and
Lindquist, 2008; Tuite et al., 2008) and makes them likely to
respond to environmental changes that create evenminor pertur-
bances in protein homeostasis (Tyedmers et al., 2008).
Interestingly, the number of cPrDs forming fluorescent fociwas
higher than the number of cPrDs forming SDS-resistant aggre-
gates in vivo. This finding, in combination with our detection ofCell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc. 155
SDS-sensitive aggregates in vitro, indicates that some cPrDs are
able to generate nonamyloid aggregates, with a low structural
stability that prevents detection by SDD-AGE. A sequence anal-
ysis of our candidates suggests one explanation for these
different behaviors. Highly amyloidogenic proteins were gener-
ally more N-rich, whereas nonamyloidogenic proteins were
more Q-rich. A direct analysis of the distinct contributions of
each of these residues to prion formation is underway and will
be reported elsewhere.
The refined set of candidate yeast prions is strongly enriched
for proteins involved in gene expression such as transcription
factors (p = 5.3 3 105) and RNA-binding proteins (p = 5.1 3
104), a finding that supports the idea that PrDs function as
epigenetic switches influencing important cellular pathways.
The discoveries of [SWI+] (Du et al., 2008) and [MOT3+] lend
further support to the idea that prion-based phenomena are bio-
logically significant. The causal agents of these prions are each
global transcription factors; consequently their prion states are
likely to have far-reaching phenotypic effects. Our in depth anal-
ysis of one of these prions, [MOT3+], reveals a very appreciable
spontaneous induction frequency (104, Figure 6 and data not
shown) that is further dramatically enhanced by overexpression
or the introduction of preformed amyloid seeds. We speculate
that the prion domain, and expression level, of Mot3p are partial
products of selection for prion bistability. The prion properties of
these transcription factors may generate an optimized pheno-
typic heterogeneity that buffers yeast populations against
diverse environmental insults.
The role of prions has expandedconsiderably since their public
inception as agents of disease. Prions in yeast and filamentous
fungi drive heritable switches that increase phenotypic diversity.
Conversely, higher organisms may have harnessed prion-like
conformational templating to initiate stable switches involved
in, for instance, neuronal synapse activation (Si et al., 2003).
The regulation and frequency of prion switching may have been
honedbyselectivepressuresunique toeachprotein.Self-perpet-
uating prion and prion-like processes that serve an adaptive role
may generally undergo increased switching under stressful
conditions that perturb protein homeostasis, as has been estab-
lished for the [PSI+] prion (Tyedmers et al., 2008).Wesuspect that
many of our confirmed prion domains, in their endogenous
contexts, will have switching rates that similarly respond to
homeostatic cues. The heterogeneity theoretically possible with
over twenty different prion switches amplifies the phenotype
space of a single proteome, creating an advantageous scenario
for any isogenic population under duress. Further, since prions
are uniquely self-perpetuating yet metastable, any beneficial
phenotype they produce can be easily maintained or lost in
subsequent generations depending on selective pressures.
This differs fundamentally both from genetic mutations, which
are usually permanent, and from nonheritable phenotypic
changes, such as those arising from transcriptional noise.
Self-templating aggregates like yeast prions constitute a para-
digm-shifting mechanism for the replication of biological infor-
mation. Prion-based biological information arises spontaneously
yet specifically within select proteins, is metastable, and is intri-
cately linked to stress-response pathways. These features posi-
tion prions as ideal bet-hedging devices (King and Masel, 2007)156 Cell 137, 146–158, April 3, 2009 ª2009 Elsevier Inc.capable of responding to environmental stimuli. Our studies
provide the tools for future genome-wide investigations of
protein-based self-perpetuating changes in diverse organisms.
We predict that these studies will profoundly impact our future
understanding of phenotypic variation and will help to unravel
the complex relationship between genotype and phenotype.
EXPERIMENTAL PROCEDURES
Computational Determination of Prion Candidates
A Hidden MarkovModel was used to identify candidate prions, with the Viterbi
algortithm used to parse proteins into prion and nonprion segments, as
detailed in Supplemental Data.
Cloning and Vector Construction
Recombination-based cloning was used to generate cPrD reporter chimeras
for yeast and bacterial expression (Alberti et al., 2007). See Table S3 for
primers and the supplement for cloning specifics.
Yeast Strains and Media
The yeast strains used in this study (Table S4) were derived from YJW509 and
YJW584 (Osherovich et al., 2004), and S288C. Standard genetic manipula-
tions and media conditions were used, as detailed in Supplemental Data.
In Vivo Aggregation Assays
cPrDswere fused to Sup35C for prion switching assays (Sondheimer and Lind-
quist, 2000), and EYFP for fluorescence microscopy. These experiments and
SDD-AGEconfirmation of SDS-resistant aggregation (Halfmann and Lindquist,
2008) were performed with modifications as detailed in Supplemental Data.
In Vitro Aggregation Assays
cPrDs were expressed in E. coli strain BL21AI as cPrD-Sup35M-His7 fusions,
except where noted, and purified under denaturing conditions. Proteins were
diluted to 20 mM into physiological buffer containing ThT and agitated contin-
uously, with fluorescence measurements taken at indicated time points. Addi-
tional details are found in Supplemental Data.
Fiber Transformation
In vitro-generated Mot3PrD-M-His7 aggregates were examined by transmis-
sion electron microscopy to confirm a fibrillar amyloid appearance, and
transformed into dan1::URA3 reporter strains usingmethodology as described
(Tanaka et al., 2006).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental Discussion, Supplemental References, eleven figures, and five tables
and can be found with this article online at http://www.cell.com/supplemental/
S0092-8674(09)00266-9.
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